41 – 50 of 1003
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1) : a single-arm, multicentre phase 1b/2 study
- Contribution to journal › Article
-
Mark
LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation
- Contribution to journal › Article
-
Mark
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients
- Contribution to journal › Article
-
Mark
Automated multiplexed affinity-based enrichment of peptides for LC-MS/MS plasma proteomics
- Contribution to journal › Article
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
- Contribution to journal › Article
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
- Contribution to journal › Scientific review
-
Mark
BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health
- Contribution to journal › Article
-
Mark
Molecular Biomarkers for Cancer Diagnosis and Therapy
Sobti, Ranbir Chander ; Sugimura, Haruhiko and Sobti, Aastha LU (2024)
- Book/Report › Anthology (editor)
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
- Contribution to journal › Scientific review
-
Mark
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
- Contribution to journal › Article
